We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$160B
AUM Growth
-$3.45B
Cap. Flow
-$2.94B
Cap. Flow %
-1.84%
Top 10 Hldgs %
28.21%
Holding
7,551
New
501
Increased
2,626
Reduced
3,452
Closed
568

Sector Composition

Rank Sector Weight
1 Technology 7.7%
2 Healthcare 5.71%
3 Financials 4.62%
4 Consumer Discretionary 4.5%
5 Communication Services 3.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGFS
7151
DELISTED
AgroFresh Solutions Inc
AGFS
-41,844
Closed -$63K
ASPU
7152
DELISTED
ASPEN GROUP, INC.
ASPU
$0 ﹤0.01%
+75
New +$338
FSTX
7153
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
-4,539
Closed -$67K
CNCE
7154
CALL
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
-21,000
Closed -$252K
OPNT
7155
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$0 ﹤0.01%
+30
New +$418
CYRN
7156
DELISTED
CYREN Ltd.
CYRN
0
REED
7157
DELISTED
Reeds, Inc. Common Stock
REED
-2
Closed
ATNX
7158
CALL
DELISTED
Athenex, Inc. Common Stock
ATNX
-250
Closed -$99K
ATNX
7159
PUT
DELISTED
Athenex, Inc. Common Stock
ATNX
-500
Closed -$198K
FFBW
7160
DELISTED
FFBW, Inc. Common Stock
FFBW
$0 ﹤0.01%
21
+10
+91% +$88
QUMU
7161
DELISTED
Qumu Corp.
QUMU
$0 ﹤0.01%
108
+99
+1,100% +$348
VIVE
7162
DELISTED
VIVEVE MED INC
VIVE
-2
Closed -$1K
RBCN
7163
DELISTED
Rubicon Technology, Inc.
RBCN
$0 ﹤0.01%
+16
New +$144
NH
7164
DELISTED
NantHealth, Inc
NH
$0 ﹤0.01%
7
-201
-97% -$1.79K
ZEN
7165
PUT
DELISTED
ZENDESK INC
ZEN
-1,600
Closed -$142K
CYBE
7166
DELISTED
Cyberoptics Corp
CYBE
$0 ﹤0.01%
+5
New +$69
QTNT
7167
CALL
DELISTED
Quotient Limited Ordinary Shares
QTNT
-1,875
Closed -$701K
SRLP
7168
DELISTED
SPRAGUE RESOURCES LP
SRLP
-82
Closed -$1K
MN
7169
DELISTED
MANNING & NAPIER, INC.
MN
-6
Closed
SHLX
7170
CALL
DELISTED
Shell Midstream Partners, L.P.
SHLX
-22,900
Closed -$474K
CVET
7171
PUT
DELISTED
Covetrus, Inc. Common Stock
CVET
-40
Closed -$1K
IEA
7172
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
-22,867
Closed -$46K
AMPE
7173
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
-417
Closed -$48K
USAK
7174
DELISTED
USA Truck Inc
USAK
$0 ﹤0.01%
39
-15,926
-100% -$140K
SHI
7175
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
-1,630
Closed -$65K

Similar funds

Barclays's Q3 2019 Portfolio in Review

As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.

  • Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
  • Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
  • Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
  • Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
  • Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
  • Barclays opened 501 new positions and closed 568 in Q3 2019.
  • Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.

Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.